You have 9 free searches left this month | for more free features.

Condition

Acute Myeloid Leukemia (AML) (1)

Multiple Myeloma (1)

Myelodysplastic Syndrome (MDS) (1)

Overall Status

Recruiting (1)

Terminated (1)

Sign in for free

Phase

phase 1 (2)

Sponsor

AbbVie (2)

Collaborator

Intervention

lemzoparlimab (2)

azacitidine (1)

carfilzomib (1)

daratumumab (1)

dexamethasone (1)

pomalidomide (1)

venetoclax (1)

Study Documents

Intervention Type

drug (2)

biological (1)

Funder Type

Industry (2)

Study Type

Interventional (2)

lemzoparlimab

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Worldwide (Lemzoparlimab, Azacitidine, Venetoclax)

Recruiting

Acute Myeloid Leukemia (AML)
Myelodysplastic Syndrome (MDS)

Lemzoparlimab
+2 more

Birmingham, Alabama
+35 more

Aug 19, 2022

Multiple Myeloma Trial in Worldwide (Lemzoparlimab, Dexamethasone, Carfilzomib)

Terminated

Multiple Myeloma

Lemzoparlimab
+4 more

Tucson, Arizona
+58 more

Jul 6, 2022